DTC Hearing By Senate Commerce Subcmte. Includes Ad Division's Ostrove
Executive Summary
FDA Division of Drug Marketing, Advertising & Communications' Nancy Ostrove, PhD, is scheduled to testify at a Senate Commerce/Consumer Affairs Subcommittee hearing on direct-to-consumer advertising May 22.
You may also be interested in...
NPC Study Finds Rx Use Reaches 60% Of Enrollees: Flaw In NIHCM Research?
A Protocare Sciences analysis of about 1 mil. health plan members finds that the number of patients per 1,000 members taking prescription drugs increased by more than 20% between 1996 and 2000.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials